Table 1 Demographic and clinical characteristics of newborns of SARS-CoV-2 positive mothers.

From: Newborns of COVID-19 mothers: short-term outcomes of colocating and breastfeeding from the pandemic’s epicenter

Characteristics Patients/Value (N = 45)
Maternal characteristics
 Age, median (IQR), years 30 (27.5–35.5)
 Vaginal delivery, no. (%) 30 (66.7)
 Cesarean section, no. (%) 15 (33.3)
 Length of stay, median (IQR), days 3 (2–3)
 Asymptomatic, no. (%) 27 (60)
 Symptomatic, no. (%) 18 (40)
 Symptoms, no. (%)
  Fever 15 (33.3)
  Cough 16 (35.6)
  Sore throat 4 (8.9)
  Shortness of breath 6 (13.3)
 Intensive care unit admission, no. (%) 2 (4.4)
 Mothers needing intubation, no. 0
 Treatment with medications for COVID-19, no. (%)  
  Hydroxychloroquine 6 (13.3)
  Azithromycin 5 (11.1)
  Tocilizumab 1 (2.2)
Newborn characteristics
 Birth weight, mean (±SD), g 3133 (±556)
 Sex, no. (%)
  Female 19 (42.2)
  Male 26 (47.8)
 Gestational age, mean (range), weeks 34 (30 5/7–41)
 Term (>37 weeks), no. (%) 41 (91.1)
 Preterm (<37 weeks), no (%) 4 (8.9)
 APGAR at 1 min, median 9
 APGAR at 5 min, median 9
 NICU admission, no. (%) 7 (15.6)
  Prematurity 3/7 (42.8)
  Suspected sepsis 4/7 (57.2)
 Isolation during initial practice, no. (%) 5 (11.1)
 Breastfeeding and colocation, no. (%)
  Roomed-in 33 (73.3)
  Breastfeeding 31/33 (94)
  Received any breastmilk 40 (88.9)
 Nasopharyngeal PCR positive for SARS-CoV-2, no. (%) 3 (6.7)
 Newborn with symptoms of COVID-19, no. 0
 Discharge disposition, no. (%)
  Discharge to the same household 40/43 (93.0)
  Discharge to different household 3 (7.0)
 Adherence to in-person newborn visit, no. (%) 39/43 (90.6)
 Symptomatic on in-person newborn visit, no. 0
Adherence to televisit, no. (%) 43/43 (100)
Symptomatic on televisit, no. 0